Sai Life Sciences is a full-service CDMO driven by a vision to support the launch of 25 new medicines by 2025.  It works with innovator pharma and biotech companies across USA, EU & Japan, accelerating the discovery, development and manufacture of complex small molecules. Over the past two decades, Sai Life Sciences has consistently delivered on a diverse set of NCE development programs for its customers with a track record of bringing value based on quality, pricing and responsiveness. Today, as one of India’s fastest growing CDMO companies, Sai Life Sciences works with the leading large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is backed by committed long-term investors, TPG Capital and HBM Healthcare Investments.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info

Top Products


Sai Life Sciences

Request Info


Sai Life Sciences

Request Info


Sai Life Sciences

Request Info


Sai Life Sciences

Request Info

Our Resources

Categories affiliated with Sai Life Sciences